158 related articles for article (PubMed ID: 8200287)
1. [Significance of platelet aggregation in patients with malignant tumor of the head and neck].
Nong HT
Zhonghua Zhong Liu Za Zhi; 1993 Nov; 15(6):454-7. PubMed ID: 8200287
[TBL] [Abstract][Full Text] [Related]
2. [Observation on platelet aggregative ability in patients with malignant tumors of head and neck by electron microscope].
Zheng Y; Liang C
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1998 Oct; 33(5):270-2. PubMed ID: 11717864
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of soluble adhesion molecules CD44 (CD44st, CD44v5, CD44v6), ICAM-1, and VCAM-1 as tumor markers in head and neck cancer.
Kawano T; Yanoma S; Nakamura Y; Shiono O; Kokatu T; Kubota A; Furukawa M; Tsukuda M
Am J Otolaryngol; 2005; 26(5):308-13. PubMed ID: 16137528
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of folate, homocysteine, and vitamin B12 in head and neck squamous cell carcinoma and in laryngeal leukoplakia.
Almadori G; Bussu F; Galli J; Cadoni G; Zappacosta B; Persichilli S; Minucci A; Giardina B; Maurizi M
Cancer; 2005 Jan; 103(2):284-92. PubMed ID: 15593092
[TBL] [Abstract][Full Text] [Related]
5. [Illness stage and IgA-anti-Fab/F(ab')2 autoantibody activity in serum of patients with malignant head-neck tumors].
Lorenz KJ; Süsal C; Opelz G; Maier H
Laryngorhinootologie; 1996 Dec; 75(12):764-8. PubMed ID: 9081283
[TBL] [Abstract][Full Text] [Related]
6. [The effect of the microenvironment of head and neck cancers on tumor progression].
Lukits J
Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
[TBL] [Abstract][Full Text] [Related]
7. Aberrant cytokine expression in serum of patients with adenoid cystic carcinoma and squamous cell carcinoma of the head and neck.
Hoffmann TK; Sonkoly E; Homey B; Scheckenbach K; Gwosdz C; Bas M; Chaker A; Schirlau K; Whiteside TL
Head Neck; 2007 May; 29(5):472-8. PubMed ID: 17111427
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of 7878 patients with tumors in the head and neck].
You MG
Zhonghua Zhong Liu Za Zhi; 1989 Jul; 11(4):282-7. PubMed ID: 2625111
[TBL] [Abstract][Full Text] [Related]
9. [Expression and significance of serum soluble tumor necrosis factor receptor-I in patients with head and neck neoplasm].
Dong W; Xu J; Qiao Z; Wang N; Yu R
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Dec; 36(6):468-70. PubMed ID: 12761967
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of interleukin-6 in patients with primary head and neck squamous cell carcinoma.
Riedel F; Zaiss I; Herzog D; Götte K; Naim R; Hörmann K
Anticancer Res; 2005; 25(4):2761-5. PubMed ID: 16080523
[TBL] [Abstract][Full Text] [Related]
11. Platelet aggregation in head and neck tumors in China.
Huang GW; Nong HT; Yu QS; Kinjoh K; Nakamura M; Kosugi T
Laryngoscope; 1997 Aug; 107(8):1142-5. PubMed ID: 9261023
[TBL] [Abstract][Full Text] [Related]
12. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
[TBL] [Abstract][Full Text] [Related]
13. [On cervical lymph node metastasizing of malignant tumors with special reference to unknown primary tumors].
Stricker G
Monatsschr Ohrenheilkd Laryngorhinol; 1969; 103(4):174-82. PubMed ID: 5783323
[No Abstract] [Full Text] [Related]
14. Impact of retropharyngeal lymph node metastasis in head and neck squamous cell carcinoma.
Gross ND; Ellingson TW; Wax MK; Cohen JI; Andersen PE
Arch Otolaryngol Head Neck Surg; 2004 Feb; 130(2):169-73. PubMed ID: 14967745
[TBL] [Abstract][Full Text] [Related]
15. [Role of the tumor marker TAG-72 in head and neck neoplasms].
Altissimi G; von Garrel C
HNO; 1990 Oct; 38(10):364-6. PubMed ID: 2283330
[TBL] [Abstract][Full Text] [Related]
16. Analysis of radiation therapy for the control of Merkel cell carcinoma of the head and neck based on 36 cases and a literature review.
Lawenda BD; Arnold MG; Tokarz VA; Silverstein JR; Busse PM; McIntyre JF; Deschler DG; Baldini EH; Kachnic LA
Ear Nose Throat J; 2008 Nov; 87(11):634-43. PubMed ID: 19006065
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of risk factors in the prediction of distant metastases of head and neck squamous cell carcinomas].
Li XM; Di B; Shang YD; Zhou YQ; Ma HM; Cheng JM
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Mar; 39(3):171-5. PubMed ID: 15283298
[TBL] [Abstract][Full Text] [Related]
18. Correlation of serum immune-reactive proteins with clinical tumor stage in patients with squamous carcinoma of the head and neck and nasopharyngeal carcinoma.
Baskies AM; Chretien PB; Wolf GT; Weiss JF
Surg Forum; 1979; 30():516-8. PubMed ID: 538683
[No Abstract] [Full Text] [Related]
19. Role for postoperative radiation therapy in adenoid cystic carcinoma of the head and neck.
Silverman DA; Carlson TP; Khuntia D; Bergstrom RT; Saxton J; Esclamado RM
Laryngoscope; 2004 Jul; 114(7):1194-9. PubMed ID: 15235347
[TBL] [Abstract][Full Text] [Related]
20. Serum nitric oxide levels in patients with head and neck squamous cell carcinoma.
Kizilay A; Kalcioğlu MT; Ozuğurlu F; Ozyurt H; Aladağ I; Ozturan O; Akyol O
Kulak Burun Bogaz Ihtis Derg; 2007; 17(3):148-51. PubMed ID: 17873505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
